PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: FDA questions maraviroc.
screen2largeMM

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.
.

PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.

Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Please read the terms of use agreement and privacy policy for this blog carefully.

FDA questions maraviroc.

FDA approval of Pfizer's HIV drug maraviroc was delayed for unknown reasons. The delay came after Question Authority published allegations about illegal premarketing, made by an internal Pfizer whistleblower.

A person inside Pfizer has now added some new information about what is going on.

This source claims that part of the problem with maraviroc is the test developed by Monogram Biosciences (MGRM). The FDA has allegedly requested for Pfizer and MGRM to explain the relationship of the test, which is not labeled, and a product that will be labeled - maraviroc.

Questions being asked are the following:

1. Who is liable if the test is not accurate and someone takes maraviroc and dies - Pfizer or Monogram Biosciences?
2. Does the test need more verification and does the FDA need to label it for safety, etc?
3. Does Pfizer need to include this in their label?
4. Does MGRM have the resources to handle the testing exclusively?
5. Does Pfizer have the right to limit the testing to one company?
6. Is the test sensitive enough?
7. How often will someone need to be tested?
8. Has Pfizer's investment in MGRM become a conflict of interest, affecting the clinical outcomes?
9. Is MGRM solvent and will they be around in a few years?

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home